Dianthus Therapeutics
DNTH
DNTH
102 hedge funds and large institutions have $729M invested in Dianthus Therapeutics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
+4
Holders Change %
+4.08%
% of All Funds
1.37%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
18
Increased
29
Reduced
40
Closed
14
Calls
$2.68M
Puts
$572K
Net Calls
+$2.11M
Net Calls Change
+$3.03M
Top Buyers
| 1 |
VPC
Vestal Point Capital
New York
|
+$27.9M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$14.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.28M |
| 4 |
Goldman Sachs
New York
|
+$5.42M |
| 5 |
Millennium Management
New York
|
+$3.64M |
Top Sellers
| 1 |
VA
VR Adviser
New York
|
-$13.9M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$13.7M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$6.81M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.99M |
| 5 |
BlackRock
New York
|
-$4.79M |
